In this study, we evaluated the clinical significance of MRP1, P-gp, and TS known to be associated with resistance of tumours to 5-FU and doxorubicin in locally advanced gastric cancer patients treated with 5-FU and doxorubicin-based adjuvant chemotherapy after curative resection. This evidence concerns the gene TYMS and neoplasm.